《2012年NCCN宫颈癌临床实践指南》解读

最近美国国立癌症综合网(National Comprehensive Cancer Network,NCCN)公布了《2012年宫颈癌临床实践指南》。2012版指南对2011年指南进行了一系列修改,解答了旧版指南中一些未予明确说明的问题。为使大家更好地了解新版指南,现对其进行简要解读。     

《2014年NCCN宫颈癌临床实践指南》解读

<正>宫颈癌位列全球女性常见癌症的第3位,85%的病例发生在发展中国家。在这些国家,宫颈癌是第2位的致死的肿瘤。2012年美国宫颈癌新发病例约12200例,其中大约4200例将死于此病。最近美国国立癌症综合网(national comprehensive cancer network,NCCN)公布了《2014年NCCN宫颈癌临床实践指南》(1版)。为使大家更好地了解新版指南,现对其进行     

《2015年NCCN宫颈癌临床实践指南》解读

在世界范围内,宫颈癌是女性第4位常见的恶性肿瘤。2012年,全球全年发生宫颈癌528 000例,年死亡数为266 000例。85%宫颈癌发生于发展中国家,并且在这些国家宫颈癌居癌症死因的首位。2014年美国大约有12 360例新发的宫颈癌病例,4 020例死亡。尽管美国妇女宫颈癌的发病率不断下降,但宫颈癌仍是一个主要的世界性健康问题。最近美国国立综合癌症网络（National Comprehensive Cancer Network,NCCN）公布了《2015年NCCN宫颈癌临床实践指南》,该指南的诊治建议适用于鳞状细胞癌、腺癌和腺鳞癌,其他类型的宫颈癌不在本指南的范围。为使大家更好地了解新版指南,现对其进行简要解读。     

《2017 NCCN宫颈癌临床实践指南》解读

<正>宫颈癌是全球范围排名第4位的常见恶性肿瘤,也是女性面临的主要健康问题。2012年全球宫颈癌发病数为52.8万例;年死亡数为26.6万例。2016年预计美国新发宫颈癌12 990例,死亡4120例。85%的宫颈癌病例发生在发展中国家,也是这些地区癌症死亡的主要原因。最近美国国立综合癌症网络(NCCN)公布了《2017宫颈癌临床实践指南》。为使大家更好地了解新版指南,现对     

《2009 NCCN宫颈癌临床实践指南》解读

编者按:《NCCN(National Comprehensive Cancer Network)肿瘤学临床实践指南》是由21家世界顶级癌症中心组成的非营利性学术联盟制订的指南,是美国肿瘤领域临床决策的标准.也已成为全球肿瘤,临床实践中应用最为广泛的指南,该指南每年均更新.最近,NCCN公布了2009卵巢癌、宫颈癌和子宫肿瘤治疗指南.为了使广大读者及时了解国际上有关妇科肿瘤的学术动态.本刊特邀请中山大学附属第二医院妇科肿瘤专家林仲秋教授对这3个指南进行解读.将分3期连续刊登.     

《2010 NCCN 宫颈癌临床实践指南》解读

编者按:(NCCN(National Comprehensive Cancer Network)肿学临床实践指南>是由21家世界顶级癌症中心组成的非营利性学术联盟制订的指南,是美国肿瘤领域临床决策的标准,也已成为全球肿瘤临床实践中应用最为广泛的指南,该指南每年均更新.     

《2009 NCCN宫颈癌临床实践指南》解读

《NCCN（Nafional Comprehensive Cancer Network）肿瘤学临床实践指南》是由21家世界顶级癌症中心组成的非营利性学术联盟制订的指南,是美国肿瘤领域临床决策的标准。也已成为全球肿瘤临床实践中应用最为广泛的指南,该指南每年均更新。最近,NCCN公布了2009卵巢癌、宫颈癌和子宫肿瘤治疗指南。为了使广大读者及时了解国际上有关妇科肿瘤的学术动态,本刊特邀请中山大学附属第二医院妇科肿瘤专家林仲秋教授对这3个指南进行解读。将分3期连续刊登。     

《2010 NCCN宫颈癌临床实践指南》解读

《NCCN（National Comprehensive Cancer Network）肿瘤学临床实践指南》是由21家世界顶级癌症中心组成的非营利性学术联盟制订的指南,是美国肿瘤领域临床决策的标准,也已成为全球肿瘤临床实践中应用最为广泛的指南,该指南每年均更新。最近,NCCN公布了2010宫颈癌、卵巢癌、子宫肿瘤治疗指南。为了使广大读者及时了解国际上有关妇科肿瘤的学术动态,我刊特邀请中山大学附属第二医院妇科肿瘤专家林仲秋教授和云南省潞西市德宏州医疗集团人民医院妇科罗祥美医生对这个指南进行解读。     

《2010NCCN宫颈癌筛查临床实践指南》解读

编者按：（NCCN（National Comprehensive Cancer Network）肿瘤学临床实践指南》是由21家世界顶级癌症中心组成的非营利性学术联盟制订的指南,是美国肿瘤领域临床决策的标准,也已成为全球肿瘤临床实践中应用最为广泛的指南,该指南每年均更新。最近,NCCN公布了2010宫颈癌筛查临床实践指南。为了使广大读者及时了解国际上有关妇科肿瘤的学术动态,我刊特邀请中山大学附属第二医院妇科肿瘤专家林仲秋教授、李晶医生和云南省潞西市德宏州医疗集团人民医院妇科罗祥美医生对这个指南进行解读。     

《2010 NCCN宫颈癌筛查临床实践指南》解读

《NCCN(National Comprehensive Cancer Network)肿瘤学临床实践指南》是由21家世界顶级癌症中心组成的非营利性学术联盟制订的指南,是美国肿瘤领域临床决策的标准,也已成为全球肿瘤临床实践中应用最为广泛的指南,该指南每年均更新。最近,NCCN公布了2010宫颈癌筛查临床实践指南。为了使广大读者及时了解国际上有关妇科肿瘤的学术动态,我刊特邀请中山大学附属第二医院妇科肿瘤专家林仲秋教授、李晶医生和云南省潞西市德宏州医疗集团人民医院妇科罗祥美医生对这个指南进行解读。     

《2009 NCCN卵巢癌临床实践指南》解读(连载三)

今年2月,NCCN公布了<2009卵巢癌临床实践指南>,2009版指南对2008版指南做了一些修订.现将2009版指南的主要更新及主要内容做一简要介绍.     

Ontario Cervical Cancer Screening Clinical Practice Guidelines

ObjectiveTo develop clinical practice guidelines for cervical screening and the primary management of abnormal cytology in Ontario, using an established methodological process.Data SourcesPrimary data sources were relevant articles listed in the Medline (1998 to July 2004), Embase (1998 to July 2004), and Cochrane Library (2004, Issue 2) databases.Study SelectionStudies addressing quality or the optimization of cervical screening were considered eligible in the systematic review of the evidence. Specifically, clinical practice guidelines, technology assessments, systematic reviews, and randomized controlled trials were of primary interest. Given the variability of the data, other information sources were considered eligible if there was a demonstrated gap in the published literature.Data ExtractionData were identified and extracted by a methodologist and reviewed by four authors. Results were reviewed and discussed by members of an expert working group consisting of a diverse group of health professionals with expertise in cervical cancer. Data audits were conducted by independent reviewers.Data SynthesisRecommendations with evidence ratings were developed through a review of the evidence with expert consensus and were approved by more than 80% of 40 external practitioners who reviewed the document and responded to a standardized survey.ConclusionThe development of comprehensive recommendations on cervical screening in Ontario was feasible using a rigorous methodological process. Recommendations for practice are provided.     

欧洲肿瘤内科协会对宫颈癌的诊断、治疗和随访所制定的临床实践指南

粗略估算欧盟国家妇女每年宫颈癌发病率13.2/100000,而病死率为5.9/100000.每年世界范围内的宫颈癌新增病例近500000,死亡274000.宫颈癌是造成妇女死亡的第三大常见原因.     

AAGL Practice Report: Practice Guidelines for Laparoscopic Subtotal/Supracervical Hysterectomy (LSH)

The first subtotal abdominal hysterectomy was described by Charles Clay in 1843, and the first laparoscopic subtotal hysterectomy (LSH) was described by Semm [1] in 1991. Whether to retain or remove the cervix remains controversial, with surgeons citing sexual satisfaction and prevention of pelvic organ prolapse as indicators for retention [2]. Because the only absolute indication for cervical removal is malignancy or its precursors, debate has continued as to the optimum surgical approach to hysterectomy for other indications. The evidence obtained from evaluating the effects of retaining the cervix, via any surgical approach, on sexual, urinary, and bowel function remains controversial 3, 4, 5, 6, 7, 8, 9, 10, 11. The literature evaluating LSH is limited, and only 3 randomized controlled trials (RCTs), including 342 women, have reported psychologic outcomes, complications, and additional cervical procedures 4, 12, 13. For the abdominal equivalent, there are 9 RCTs, including 1553 women, and a Cochrane review reported few important differences between the 2 approaches [8]. No such comparative data are available for LSH. This practice guideline will evaluate the evidence for LSH. This report was developed under the direction of the Practice Committee of the AAGL as a service to their members and other practicing clinicians.